Rybelsus®

Semaglutide

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.
more
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
Rp 245269.33
Rp 22074239.31Rp 245269.33
Rp 2941705.73
60 tablet
Free AirMail shipping Hot
Rp 261616.68
Rp 15697000.65Rp 261616.68
Rp 980296.05
30 tablet
Free AirMail shipping Hot
Rp 277954.94
Rp 8338648.35Rp 277954.94
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
Rp 294325.01
Rp 26489250.69Rp 294325.01
Rp 1470035.27
60 tablet
Free AirMail shipping Hot
Rp 302496.41
Rp 18149784.75Rp 302496.41
Rp 489739.23
30 tablet
Free AirMail shipping Hot
Rp 310658.73
Rp 9319761.99Rp 310658.73
Package Per pill Price Savings Order
90 tablet
Free AirMail shipping Hot
Rp 351556.64
Rp 31640097.30Rp 351556.64
Rp 1470035.27
60 tablet
Free AirMail shipping Hot
Rp 359728.04
Rp 21583682.49Rp 359728.04
Rp 489739.23
30 tablet
Free AirMail shipping Hot
Rp 367890.36
Rp 11036710.86Rp 367890.36
Rybelsus

Brand(s)

Manufacturer

  • Novo Nordisc India Pvt. Ltd

Disease(s)

  • Type 2 Diabetes Mellitus / High Blood Sugar

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.